Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Beijing Dabeinong Technology Group Co.,Ltd.
  6. News
  7. Summary
    002385   CNE100000N61

BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.

(002385)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

China plans overhaul of seed rules to pave way for GMO approvals

11/14/2021 | 10:52pm EST

BEIJING, Nov 15 (Reuters) - China has laid out a clear path for seed makers to get approval for genetically modified crops, under proposed rule changes that should lead to commercial cultivation of GM corn.

Details of the planned regulatory overhaul for the seed industry were published on Friday by the agriculture ministry in a draft document that is open for public comment until Dec. 12.

The proposed changes mean that a handful of recently approved GM traits developed by Chinese companies could be ready for market launch in a year.

"It's a big step," said Liu Shi, a vice president of Beijing Dabeinong Technology Group Co Ltd, which has several GM traits approved as safe and is expected to be one of the first firms to commercialise GM corn in China.

Shares of Dabeinong shares fell 6% on Monday, while those of rival Yuan Longping High-Tech Agriculture Co Ltd fell 10%.

China's leadership called last year for an urgent "turnaround" in the seed industry, which is struggling with overcapacity and rampant infringement of intellectual property that has stifled innovation.

The changes implement decisions by the cabinet and the powerful central committee of the ruling Communist Party on safe management of GMOs (genetically modified organisms) and development of a modern seed industry, the ministry of agriculture and rural affairs said in its statement.

Top policymakers have also urged progress in biotech breeding, or GM crops, seen as key to ensuring food security.

While investing heavily in GM research and development for years, Beijing has remained cautious, barring the planting of GM soybeans or corn, despite allowing imports for use in animal feed.

Once approved, China could plant 33 million hectares with GM corn, estimated Hua'an Securities in a note on Sunday, generating up to 5 billion yuan in income, while also creating strong market leaders and driving rapid consolidation in the industry.

The proposed changes would bring China's regulations more in line with those of other markets.

If a GM trait, also known as an 'event', has already been approved as safe by the agriculture ministry, it can be integrated into an already approved corn hybrid, for example, and only requires a one-year production trial to verify that the combination is still safe.

Previously, it was thought that China might require the product to once again undergo all safety trials from scratch.

"It clarifies the procedures for GMO variety approvals and simplifies the process," said Han Gengchen, chairman of Origin Agritech Ltd, the first Chinese company to develop GM corn crops.

"It will accelerate GMO corn commercial production."

It is still unclear when the first commercial crops would be approved.

Dabeinong is ready to start production trials now for its DBN9936 insect-resistant and herbicide-tolerant corn, said Liu, and is also "bulking up" its in-bred lines to produce enough parent seed to prepare for commercial sales.

If production trials are completed by the end of 2022 and approval granted, Dabeinong could start small-scale commercial sales in spring 2023.

It is unclear if Beijing would recognise previous field demonstration trials done by Dabeinong and allow approval earlier, said Liu.

Hangzhou Ruifeng Biotech Co Ltd, in which Yuan Longping owns a 41.8% stake, also has an insect-resistant, herbicide-tolerant GM event approved as safe by China. (Reporting by Dominique Patton; Editing by Hugh Lawson, Clarence Fernandez and Simon Cameron-Moore)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD. 0.74% 9.51 End-of-day quote.-9.34%
ORIGIN AGRITECH LIMITED 4.99% 7.36 Delayed Quote.2.65%
YUAN LONG PING HIGH-TECH AGRICULTURE CO., LTD. 2.31% 20.37 End-of-day quote.-12.42%
All news about BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.
01/11Dabeinong Technology Offers Bonuses to Encourage Employees to Have More Children
MT
2021China to give safety approval to more domestic GMO corn types
RE
2021Biotech Firm Dabeinong Expects to Gain From Opening Up of China's $120 Billion GM Corn ..
MT
2021Beijing biotech firm banks on GM corn in race to be China's Monsanto
RE
2021Guangdong Giant Agricultural Biotechnology Co., Ltd. announced that it expects to recei..
CI
2021China Drafts New Seed Industry Rules to Ease GMO Approvals
MT
2021China plans overhaul of seed rules to pave way for GMO approvals
RE
2021Beijing Dabeinong Technology Group Co.,Ltd. Approves Election of Independent Directors
CI
2021Beijing Dabeinong Technology Group Co.,Ltd. Reports Earnings Results for the Nine Month..
CI
2021Beijing Dabeinong Technology Group Co.,Ltd. agreed to acquire additional 11.36% stake i..
CI
More news
Financials
Sales 2021 29 128 M 4 588 M 4 588 M
Net income 2021 492 M 77,6 M 77,6 M
Net Debt 2021 2 503 M 394 M 394 M
P/E ratio 2021 79,1x
Yield 2021 0,35%
Capitalization 39 384 M 6 204 M 6 204 M
EV / Sales 2021 1,44x
EV / Sales 2022 1,23x
Nbr of Employees 19 414
Free-Float 65,9%
Chart BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.
Duration : Period :
Beijing Dabeinong Technology Group Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 9,51 CNY
Average target price 8,95 CNY
Spread / Average Target -5,92%
EPS Revisions
Managers and Directors
Li Zhong Zhang President & Director
Gen Huo Shao Chairman
Xuan Li Independent Director
Wei Ping Song Director & Vice President
Jie Zhang Member-Supervisory Board